Specialty Connect 2018 Bundle!

Login to Purchase Now!

 

Given the significant clinical and economic complexities surrounding the treatment of hemophilia, it is imperative that managed care professionals understand the disease state, evolving standards of care and emerging therapeutic options.  Specialty Connect 2018 is designed for industry leaders, experts and managed care pharmacists operating in the fast-growing specialty sector.  This previously presented program will provide a thorough immersion in the concepts most important to quality hemophilia management.  Ensuring optimal cost-effective care in hemophilia has never been more important.  

Here are the home study actvities included in this bundle:

  • The Present and Future of Hemophilia Treatment
  • Managing Patients with Hemophilia: A Payer’s Perspective
  • Gene Therapy for Hemophilia: Hope for a Cure?
  • Perspectives in Hemophilia Management: A Panel Discussion

Products

Found 4
Sort by
Home Study Programs
Log In

The Present and Future of Hemophilia Treatment- Bundle

Contact Hours: 1.0. Over the past few decades, the treatment of hemophilia has been transformed by the emergence of safer clotting factor replacement products, and the growing use of prophylactic therapy to prevent bleeding and joint destruction.
Hemophilia
Home Study Programs
Log In

Perspectives in Hemophilia Management - Bundle

Contact Hours: 1.0. The treatment of hemophilia has evolved from a one-size-fits-all approach to a highly individualized care approach, and it continues to become more
patient-centered and specific.
Hemophilia
Home Study Programs
Log In

Managing Patients with Hemophilia: A Payer’s Perspective- Bundle

Contact Hours: 1.0. Thanks to significant improvements in the treatment of hemophilia, patients are living longer than ever before, with higher expectations for
near-normal quality of life.
Hemophilia
Home Study Programs
Log In

Gene Therapy for Hemophilia: Hope for a Cure?- Bundle

Contact Hours: 0.75. The best currently available treatments for hemophilia reduce but do not eliminate the possibility of bleeding.
Hemophilia